section name header

Pronunciation ⬇

fen-az-oh-PEER-i-deen

Classifications ⬆ ⬇

Therapeutic Classification: nonopioid analgesics

Pharmacologic Classification: urinary tract analgesics

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

  • Acts locally on the urinary tract mucosa to produce analgesic or local anesthetic effects.
  • Has no antimicrobial activity.
Therapeutic effects:
  • Diminished urinary tract discomfort.

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed following oral administration.

Distribution: Unknown.

Metabolism/Excretion: Rapidly excreted unchanged in the urine.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

(urinary analgesia)

ROUTEONSETPEAKDURATION
POunknown5–6 hr6–8 hr

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: rash

GI: hepatotoxicity, nausea

GU: bright-orange urine, renal failure

Hemat: hemolytic anemia, methemoglobinemia

Neuro: headache, vertigo

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Pyridium

Code ⬆

NDC Code